Viruses use the molecular repertoire of the host cell to duplicate. Researchers need to exploit this for the therapy of influenza. The staff recognized a compound that inhibits the physique’s personal methyltransferase MTr1, thereby limiting the replication of influenza viruses. The compound proved efficient in lung tissue preparations and mouse research and confirmed synergistic results with already authorised influenza medicine.